HAONasdaqServices-Advertising AgenciesFiscal year ends June 30
Haoxi Health Technology Ltd
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Sep 30, 2026
$2.06−0.05 (-2.37%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2021 to 2026
Gross margin
1.1%
Operating margin
-17.6%
Net margin
-17.4%
Growth rates
Compound annual growth to fiscal 2026
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +67.1% | +24.8% | – | – | |
| Gross profit | -32.2% | -32.7% | – | – |
Returns and balance sheet
6 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2021 | FY2021 | FY2026 | Trend |
|---|---|---|---|---|
| Return on equity | – | – | -54.1% | |
| Return on assets | – | – | -44.2% | |
| Current ratio | – | – | 4.53 | |
| Debt to equity | – | – | – | |
| Net debt to EBITDA | – | – | – | |
| Interest coverage | – | – | -184.3× | |
| Capex to revenue | – | – | – | |
| Diluted shares | – | – | 0M |
Cash use needs five years of cash flow figures
Haoxi Health Technology does not report operating cash flow and capital expenditure for each of the last five fiscal years.
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin-17.4%
×Asset turnover2.54×
×Equity multiplier1.23×
=Return on equity, FY2026-54.1%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2026 | -17.4% | 2.54× | 1.23× | -54.1% |
| FY2025 | 11.8% | 1.77× | 1.30× | 27.1% |
| FY2024 | 2.7% | 4.86× | 1.56× | 20.1% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2026 against fiscal 2025
2of 8 tests passed in fiscal 2026. Some tests lack the figures they need.
- ProfitableNet income above zero-$9.54M
- Cash generatingOperating cash flow above zero-$2.57M
- Return on assets improvedROA up on the prior year25.0% → -44.2%
- Earnings backed by cashOperating cash flow above net income-$2.57M vs -$9.54M
- Less leverageLong-term debt to assets fell1.4% → –
- Better liquidityCurrent ratio rose5.01 → 4.53
- No dilutionShare count did not rise0M → 0M
- Gross margin improvedGross margin up on the prior year2.83% → 1.15%
- More efficientAsset turnover rose2.12 → 2.54